AT1 Receptor Antagonist Candesartan Attenuates Genomic Damage in Peripheral Blood Lymphocytes of Patients on Maintenance Hemodialysis Treatment.
All authors: Schupp N, Rutkowski P, Sebekova K, Klassen A, Bahner U, Grupp C, Heidland A, Stopper H
Search Results Kidney and Blood Pressure Research, 34 (3): 167-172, 2011


